Mucocutaneous manifestations of HIV/AIDS infection: literature review

Mutia Devi (Department of Dermatology and Venereology, Medical Faculty of Universitas Sriwijaya/ Dr. Mohammad Hoesin General Hospital, Palembang, Indonesia)
Muhammad Izazi Hari Purwoko (Department of Dermatology and Venereology, Medical Faculty of Universitas Sriwijaya/ Dr. Mohammad Hoesin General Hospital, Palembang, Indonesia)
Suroso Adi Nugroho (Department of Dermatology and Venereology, Medical Faculty of Universitas Sriwijaya/ Dr. Mohammad Hoesin General Hospital, Palembang, Indonesia)
Yulia Farida Yahya (Department of Dermatology and Venereology, Medical Faculty of Universitas Sriwijaya/ Dr. Mohammad Hoesin General Hospital, Palembang, Indonesia)
Indah Astri Aryani (Department of Dermatology and Venereology, Medical Faculty of Universitas Sriwijaya/ Dr. Mohammad Hoesin General Hospital, Palembang, Indonesia)
Kiki Septiafni (Department of Dermatology and Venereology, Medical Faculty of Universitas Sriwijaya/ Dr. Mohammad Hoesin General Hospital, Palembang, Indonesia)

Bali Dermatology Venereology and Aesthetic Journal
BDVJ - Vol. 5 No. 2 (December 2022)

Mucocutaneous manifestations are the first recognized human immunodeficiency virus (HIV) infections. More than 90% of HIV-infected patients develop at least one or more types of typical or atypical skin lesions during the disease. Mucocutaneous manifestation can also indicate the progression of HIV infection and cluster of differentiation 4 (CD4) cell count as an indicator of the development of acquired immunodeficiency syndrome (AIDS). It is important to know mucocutaneous manifestations and their correlation with the patient’s immune status to provide appropriate treatment to improve the patient’s quality of life.